查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1819913

2025 年至 2033 年藥物發現資訊學市場報告（按工作流程、功能、模式、最終用戶（製藥公司、生物技術公司、合約研究組織等）和地區分類）

Drug Discovery Informatics Market Report by Workflow, Function, Mode, End User (Pharmaceutical Companies, Biotechnology Companies, Contract Research Organization, and Others), and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 137 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球藥物發現資訊學市場規模達 36 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 84 億美元，2025-2033 年期間的成長率 (CAGR) 為 9.21%。

藥物研發資訊學是一種用於分析和解讀大量生化資料的技術解決方案。這些資料源自於臨床實驗室為研究目的而進行的實驗，並用於為各種藥物的研發提供見解。它涉及眾多基於軟體和硬體的工具，用於藥物研發的定序、標靶資料分析、資料視覺化、對接、分子建模和資料庫保護。因此，它被醫療機構、製藥和生物技術組織以及合約研究組織 (CRO) 廣泛應用。

全球醫療保健和製藥行業的顯著成長是市場前景樂觀的關鍵因素之一。此外，慢性疾病的日益普及以及對治療罕見疾病的有效解決方案的需求不斷成長，也促進了市場的成長。藥物發現資訊學被製藥機構廣泛用於分析新藥實體和處理來自多個來源的生物資訊。此外，各種技術進步，例如基於生理的藥物動力學 (PBPK) 模擬器平台的開發，該平台透過建模和模擬幫助預測藥物動力學結果，也是其他成長誘導因素。同時，政府和私人醫療機構加大對孤兒藥研發的投資也促進了市場的成長。其他因素，包括老年人口的成長以及生物資訊學領域廣泛的研發活動，預計將進一步推動市場的發展。

本報告回答的關鍵問題：

  • 全球藥物發現資訊學市場迄今表現如何？未來幾年將如何表現？
  • COVID-19 對全球藥物發現資訊學市場有何影響？
  • 主要的區域市場有哪些？
  • 根據工作流程，市場是如何分類的？
  • 根據功能對市場進行怎樣的細分？
  • 根據模式，市場區隔是怎麼樣的？
  • 根據最終用戶，市場是如何分類的？
  • 該產業的價值鏈分為哪些階段？
  • 該行業的主要促進因素和挑戰是什麼？
  • 全球藥物發現資訊學市場的結構是怎麼樣的？主要參與者是誰？
  • 產業競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球藥物發現資訊學市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依工作流程

  • 藥物研發
  • 藥物開發

第7章：市場區隔：依功能

  • 序列分析平台
  • 分子建模
  • 分子對接
  • 臨床試驗數據管理
  • 其他

第8章：市場區隔：依模式

  • 外包
  • 內部

第9章：市場區隔：依最終用戶

  • 製藥公司
  • 生技公司
  • 合約研究組織（CRO）
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第 11 章：SWOT 分析

第 12 章：價值鏈分析

第 13 章：波特五力分析

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Accenture PLC
    • Certara
    • Charles River Laboratories Inc.
    • Collaborative Drug Discovery Inc.
    • Eurofins DiscoverX Products
    • Infosys Ltd.
    • International Business Machines Corporation
    • Jubilant Biosys Limited
    • Oracle Corporation
    • PerkinElmer Inc.
    • Selvita
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A3515

The global drug discovery informatics market size reached USD 3.6 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 8.4 Billion by 2033, exhibiting a growth rate (CAGR) of 9.21% during 2025-2033.

Drug discovery informatics is a technological solution used for analyzing and interpreting large volumes of biochemical data. The data is generated from the experiments conducted in clinical laboratories for research purposes and utilized for generating insights regarding the development of various drugs. It involves numerous software and hardware-based tools for sequencing, target data analysis, data visualization, docking, molecular modelling, database protection for drug discovery and development. As a result, it is widely used by healthcare institutions, pharmaceutical and biotechnology organizations and contract research organizations (CROs).

Significant growth in the healthcare and pharmaceutical industries across the globe represents one of key the factors creating a positive outlook for the market. Furthermore, the increasing prevalence of chronic medical disorders and the escalating requirement for effective solutions to treat rare diseases are also augmenting the market growth. Drug discovery informatics is widely used by pharmaceutical organizations for the analysis of new drug entities and handling of the biological information from multiple sources. Additionally, various technological advancements, such as the development of innovative Physiologically-based Pharmacokinetic (PBPK) Simulator platforms, which aid in predicting pharmacokinetic outcomes through modeling and simulation, are acting as other growth-inducing factors. In line with this, increasing investments by government and private healthcare institutions to develop orphan drugs is also contributing to the market growth. Other factors, including the rising geriatric population, along with extensive research and development (R&D) activities in the field of bioinformatics, are anticipated to drive the market further.

Key Market Segmentation:

Breakup by Workflow:

  • Drug Discovery
  • Drug Development

Breakup by Function:

  • Sequence Analysis Platforms
  • Molecular Modelling
  • Molecular Docking
  • Clinical Trial Data Management
  • Others

Breakup by Mode:

  • Outsourced
  • In-house

Breakup by End User:

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Research Organization (CROs)
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Accenture Plc, Certara, Charles River Laboratories Inc., Collaborative Drug Discovery Inc., Eurofins DiscoverX Products, Infosys Ltd., International Business Machines Corporation, Jubilant Biosys Limited, Oracle Corporation, PerkinElmer Inc., Selvita and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report:

  • How has the global drug discovery informatics market performed so far and how will it perform in the coming years ?
  • What has been the impact of COVID-19 on the global drug discovery informatics market ?
  • What are the key regional markets ?
  • What is the breakup of the market based on the workflow ?
  • What is the breakup of the market based on the function ?
  • What is the breakup of the market based on the mode ?
  • What is the breakup of the market based on the end user ?
  • What are the various stages in the value chain of the industry ?
  • What are the key driving factors and challenges in the industry ?
  • What is the structure of the global drug discovery informatics market and who are the key players ?
  • What is the degree of competition in the industry ?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Drug Discovery Informatics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Workflow

  • 6.1 Drug Discovery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Drug Development
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Function

  • 7.1 Sequence Analysis Platforms
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Molecular Modelling
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Docking
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Clinical Trial Data Management
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Mode

  • 8.1 Outsourced
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 In-house
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Biotechnology Companies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Contract Research Organization (CROs)
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Accenture PLC
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Certara
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Charles River Laboratories Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 Collaborative Drug Discovery Inc.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Eurofins DiscoverX Products
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Infosys Ltd.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 International Business Machines Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Jubilant Biosys Limited
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Oracle Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 PerkinElmer Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Selvita
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Drug Discovery Informatics Market: Major Drivers and Challenges
  • Figure 2: Global: Drug Discovery Informatics Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Drug Discovery Informatics Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Drug Discovery Informatics Market: Breakup by Workflow (in %), 2024
  • Figure 5: Global: Drug Discovery Informatics Market: Breakup by Function (in %), 2024
  • Figure 6: Global: Drug Discovery Informatics Market: Breakup by Mode (in %), 2024
  • Figure 7: Global: Drug Discovery Informatics Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Drug Discovery Informatics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Drug Discovery Informatics (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Drug Discovery Informatics (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Drug Discovery Informatics (Drug Development) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Drug Discovery Informatics (Drug Development) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Drug Discovery Informatics (Sequence Analysis Platforms) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Drug Discovery Informatics (Molecular Modelling) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Drug Discovery Informatics (Molecular Modelling) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Drug Discovery Informatics (Molecular Docking) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Drug Discovery Informatics (Molecular Docking) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Drug Discovery Informatics (Clinical Trial Data Management) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Drug Discovery Informatics (Other Functions) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Drug Discovery Informatics (Other Functions) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Drug Discovery Informatics (Outsourced) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Drug Discovery Informatics (Outsourced) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Drug Discovery Informatics (In-house) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Drug Discovery Informatics (In-house) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Drug Discovery Informatics (Pharmaceutical Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Drug Discovery Informatics (Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Drug Discovery Informatics (Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Drug Discovery Informatics (Contract Research Organization (CROs)) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Drug Discovery Informatics (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Drug Discovery Informatics (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: North America: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: North America: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: United States: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: United States: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Canada: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Canada: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Asia-Pacific: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Asia-Pacific: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: China: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: China: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Japan: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Japan: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: India: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: India: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: South Korea: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: South Korea: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Australia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Australia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Indonesia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Indonesia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Europe: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Europe: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Germany: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Germany: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: France: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: France: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: United Kingdom: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: United Kingdom: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Italy: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Italy: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Spain: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Spain: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Russia: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Russia: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Latin America: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Latin America: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Brazil: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Brazil: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Mexico: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Mexico: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Others: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Others: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Middle East and Africa: Drug Discovery Informatics Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Middle East and Africa: Drug Discovery Informatics Market: Breakup by Country (in %), 2024
  • Figure 83: Middle East and Africa: Drug Discovery Informatics Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 84: Global: Drug Discovery Informatics Industry: SWOT Analysis
  • Figure 85: Global: Drug Discovery Informatics Industry: Value Chain Analysis
  • Figure 86: Global: Drug Discovery Informatics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Drug Discovery Informatics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Drug Discovery Informatics Market Forecast: Breakup by Workflow (in Million USD), 2025-2033
  • Table 3: Global: Drug Discovery Informatics Market Forecast: Breakup by Function (in Million USD), 2025-2033
  • Table 4: Global: Drug Discovery Informatics Market Forecast: Breakup by Mode (in Million USD), 2025-2033
  • Table 5: Global: Drug Discovery Informatics Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Drug Discovery Informatics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Drug Discovery Informatics Market: Competitive Structure
  • Table 8: Global: Drug Discovery Informatics Market: Key Players